Association of advanced therapies for intermediate- to high-risk pulmonary embolism with improved right ventricular function on outpatient follow-up among survivors - Takeaways - MDSpire

Association of advanced therapies for intermediate- to high-risk pulmonary embolism with improved right ventricular function on outpatient follow-up among survivors

  • By

  • Hammad Sheikh

  • Avinash Singh

  • Connor Smith

  • Howard Freeman

  • Abdul Rehman

  • Jeeyune Bahk

  • Sakul

  • Keshav Dixit

  • Alvin Yang

  • Maria Riasat

  • Robert Lookstein

  • Edgar Argulian

  • David J. Steiger

  • June 10, 2026

  • 0 min

Share

  • 1

    The study evaluated the impact of advanced therapies on right ventricular function in outpatients with acute pulmonary embolism.

  • 2

    A total of 122 patients were included, with a median age of 64.4 years and varying risk classifications for pulmonary embolism.

  • 3

    Advanced therapies included catheter-directed embolectomy, catheter-directed thrombolysis, and surgical pulmonary embolectomy.

  • 4

    Receipt of advanced therapies was associated with significant improvements in echocardiographic parameters of right ventricular function.

  • 5

    The findings suggest that advanced therapies may enhance recovery in survivors of acute pulmonary embolism, warranting further prospective studies.

Original Source(s)

Related Content